Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lynnette C. Johnson"'
Autor:
Tom E. Forshaw, Julie A. Reisz, Kimberly J. Nelson, Rajesh Gumpena, J. Reed Lawson, Thomas J. Jönsson, Hanzhi Wu, Jill E. Clodfelter, Lynnette C. Johnson, Cristina M. Furdui, W. Todd Lowther
Publikováno v:
Antioxidants, Vol 10, Iss 6, p 946 (2021)
Human peroxiredoxins (Prx) are a family of antioxidant enzymes involved in a myriad of cellular functions and diseases. During the reaction with peroxides (e.g., H2O2), the typical 2-Cys Prxs change oligomeric structure between higher order (do)decam
Externí odkaz:
https://doaj.org/article/d55fdb246166416a82421dcc5de5c96d
Autor:
Cristina M. Furdui, Jill E. Clodfelter, J. Reed Lawson, Julie A. Reisz, Hanzhi Wu, W. Todd Lowther, Rajesh Gumpena, Lynnette C. Johnson, Thomas J. Jönsson, Kimberly J. Nelson, Tom E. Forshaw
Publikováno v:
Antioxidants
Antioxidants, Vol 10, Iss 946, p 946 (2021)
Volume 10
Issue 6
Antioxidants, Vol 10, Iss 946, p 946 (2021)
Volume 10
Issue 6
Human peroxiredoxins (Prx) are a family of antioxidant enzymes involved in a myriad of cellular functions and diseases. During the reaction with peroxides (e.g., H2O2), the typical 2-Cys Prxs change oligomeric structure between higher order (do)decam
Autor:
Travis J Riedel, Lynnette C Johnson, John Knight, Roy R Hantgan, Ross P Holmes, W Todd Lowther
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e26021 (2011)
4-hydroxy-2-oxoglutarate (HOG) aldolase is a unique enzyme in the hydroxyproline degradation pathway catalyzing the cleavage of HOG to pyruvate and glyoxylate. Mutations in this enzyme are believed to be associated with the excessive production of ox
Externí odkaz:
https://doaj.org/article/c240ed0aa19144a8b5b3d254279b01cc
Autor:
Jill E. Clodfelter, Brian E. Fulp, Charles W. Pemble, Lynnette C. Johnson, Cristina M. Furdui, Melissa K. Ritchie, W. Todd Lowther, Steven J. Kridel
Publikováno v:
Journal of Biological Chemistry. 291:3520-3530
The type I fatty acid synthase (FASN) is responsible for the de novo synthesis of palmitate. Chain length selection and release is performed by the C-terminal thioesterase domain (TE1). FASN expression is up-regulated in cancer, and its activity leve
Autor:
Thomas J. Jönsson, Candice B. Summitt, Derek Parsonage, Ross P. Holmes, W. Todd Lowther, Lynnette C. Johnson
Publikováno v:
Biochemical Journal. 466:273-281
The primary hyperoxalurias (PH), types 1–3, are disorders of glyoxylate metabolism that result in increased oxalate production and calcium oxalate stone formation. The breakdown of trans-4-hydroxy-L-proline (Hyp) from endogenous and dietary sources
Publikováno v:
Journal of Biological Chemistry. 284:33305-33310
Oxidative stress can damage the active site cysteine of the antioxidant enzyme peroxiredoxin (Prx) to the sulfinic acid form, Prx-SO(2)(-). This modification leads to inactivation. Sulfiredoxin (Srx) utilizes a unique ATP-Mg(2+)-dependent mechanism t
Publikováno v:
Journal of Biological Chemistry. 283:23846-23851
Sulfiredoxin (Srx) catalyzes a novel enzymatic reaction, the reduction of protein cysteine sulfinic acid, \documentclass[10pt]{article} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepacka
Publikováno v:
Nature. 451:98-101
The X-ray crystal structure of peroxiredoxin bound to sulphiredoxin is solved. In this structure of the co-complex, the carboxy terminus of peroxiredoxin is completely unfolded, and it is 'packed' onto the backside of sulphiredoxin, away from the sul
Publikováno v:
Nature Structural & Molecular Biology. 14:704-709
Human fatty acid synthase (FAS) is uniquely expressed at high levels in many tumor types. Pharmacological inhibition of FAS therefore represents an important therapeutic opportunity. The drug Orlistat, which has been approved by the US Food and Drug
Autor:
W. Todd Lowther, Herbert Weissbach, Mark O. Lively, Zhidong Lin, Lynnette C. Johnson, Nathan Brot
Publikováno v:
Proceedings of the National Academy of Sciences. 104:9597-9602
The reduction of methionine sulfoxide (MetO) is mediated by methionine sulfoxide reductases (Msr). The MsrA and MsrB families can reduce free MetO and MetO within a peptide or protein context. This process is stereospecific with the S - and R -forms